Insights and expectations on Japanese investors and pharmaceutical companies
Bowen Gu, Investor Engagement Manager at the Access to Medicine Foundation talks to Etsuya Hirose, Nakatsuka Kazunori and Ayaka Hirai in this QUICK ESG interview.
Bowen shares key findings of the 2018 Index, together with insights into Japanese investors and pharmaceutical companies.
"Amongst the Japanese companies that we cover we see progress over the years. Takeda, in particular, jumped 10 places from 15th to 5th.
We have [also] seen increasing interests from Japanese investors. Signing up to the Investor Statement is the first step, but the next step is using the Index in engagements substantively."